KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

ClearPoint Neuro (CLPT) Return on Equity (2018 - 2025)

ClearPoint Neuro's Return on Equity history spans 12 years, with the latest figure at 1.31% for Q3 2025.

  • For Q3 2025, Return on Equity fell 72.0% year-over-year to 1.31%; the TTM value through Sep 2025 reached 1.31%, down 72.0%, while the annual FY2024 figure was 0.85%, 7.0% down from the prior year.
  • Return on Equity for Q3 2025 was 1.31% at ClearPoint Neuro, down from 1.13% in the prior quarter.
  • Across five years, Return on Equity topped out at 0.22% in Q2 2021 and bottomed at 1.31% in Q3 2025.
  • The 5-year median for Return on Equity is 0.54% (2024), against an average of 0.62%.
  • The largest annual shift saw Return on Equity soared 892bps in 2021 before it tumbled -72bps in 2025.
  • A 5-year view of Return on Equity shows it stood at 0.31% in 2021, then tumbled by -39bps to 0.43% in 2022, then plummeted by -130bps to 0.99% in 2023, then grew by 29bps to 0.71% in 2024, then tumbled by -86bps to 1.31% in 2025.
  • Per Business Quant, the three most recent readings for CLPT's Return on Equity are 1.31% (Q3 2025), 1.13% (Q2 2025), and 0.93% (Q1 2025).